🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to assess the effects of LIK066 on a variety ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-10-04
Trial ID
NCT03205150
This study will assess safety, tolerability, and effect of LIK066 on blood ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-06
Trial ID
NCT01407003
The purpose of this study was to determine if LIK066 taken with a meal cont...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-06-21
Trial ID
NCT03198767
This was a dose-finding study that evaluated the change in weight after 24 ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-05-06
Trial ID
NCT03100058
The purpose of the study is to evaluate the efficacy, tolerability and safe...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-12-07
Trial ID
NCT03320941
This was a dose-finding study to evaluate the efficacy, safety and tolerabi...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2017-07-25
Trial ID
NCT03152552
Treatments Being Tested
The purpose of the study was to assess the effect of LIK066 on intestinal g...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-07
Trial ID
NCT01915849
The purpose of this trial was to evaluate whether the study drug, LIK066, c...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-04-28
Trial ID
NCT03131479
Treatments Being Tested
The purpose of the study was to evaluate whether LIK066 can be developed fo...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-07-24
Trial ID
NCT03152591
The purpose of the study is to evaluate the efficacy, tolerability and shor...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT01824264
Treatments Being Tested